Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surge

Trial Details

NCT ID
NCT06290427
Phase
NA
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Status
RECRUITING
Cancer Type
Kidney Cancer
Interventions
  • DaVinci RAPN
  • Hugo RAS RAPN
Locations (sample)
  • Verona, VR, Italy|45.43854,10.9938

Key Eligibility Criteria

  • patient aged between 18 and 90 years old;
  • patient with localized kidney tumor suitable for partial nephrectomy;
  • patient able to understand and sign the informed consent;
  • patient compliance with the follow-up program.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Kidney Cancer Trials on Trialify →